EKSO BIONICS HOLDINGS, INC.·4

Mar 28, 4:44 PM ET

Jones Jason C 4

4 · EKSO BIONICS HOLDINGS, INC. · Filed Mar 28, 2022

Insider Transaction Report

Form 4
Period: 2022-03-22
Jones Jason C
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2022-03-22$2.82/sh3,265$9,20681,637 total
Footnotes (2)
  • [F1]Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021.
  • [F2]The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION